Athersys (ATHX) Misses Q1 EPS by 7c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/5/2026

1. NVDA
2. SPY
3. PTC
4. META
5. PCVX
6. USO
7. MSFT
8. AMZN
9. AMD
10. ATH

Go back to Athersys (ATHX) Misses Q1 EPS by 7c

Athersys Reports First Quarter 2015 Results

May 11, 2015 4:05 PM EDT

CLEVELAND, May 11, 2015 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq: ATHX) today announced its financial results for the three months ended March 31, 2015.

Highlights of the first quarter of 2015 and recent events include:

Entered into an exclusive license agreement with Chugai Pharmaceutical Co., Ltd. (Chugai) to develop and commercialize our MultiStem® cell therapy for the treatment of ischemic stroke in Japan, which included an up-front payment of $10 million and an additional $195 million of potential future payments and royalties;Announced interim results from the Phase 2 clinical study of MultiStem to... More